<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Kim JW</submitter><funding>National Research Foundation of Korea (NRF)</funding><funding>National Research Foundation of Korea</funding><pagination>567</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10460413</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>14(8)</volume><pubmed_abstract>Ferroptosis, a type of cell death induced by lipid peroxidation, has emerged as a novel anti-cancer strategy. Cancer cells frequently acquire resistance to ferroptosis. However, the underlying mechanisms are poorly understood. To address this issue, we conducted a thorough investigation of the genomic and transcriptomic data derived from hundreds of human cancer cell lines and primary tissue samples, with a particular focus on non-small cell lung carcinoma (NSCLC). It was observed that mutations in Kelch-like ECH-associated protein 1 (KEAP1) and subsequent nuclear factor erythroid 2-related factor 2 (NRF2, also known as NFE2L2) activation are strongly associated with ferroptosis resistance in NSCLC. Additionally, AIFM2 gene, which encodes ferroptosis suppressor protein 1 (FSP1), was identi</pubmed_abstract><journal>Cell death &amp; disease</journal><pubmed_title>FSP1 confers ferroptosis resistance in KEAP1 mutant non-small cell lung carcinoma in NRF2-dependent and -independent manner.</pubmed_title><pmcid>PMC10460413</pmcid><funding_grant_id>2021R1C1C1003988</funding_grant_id><funding_grant_id>2022R1A2C4002108</funding_grant_id><pubmed_authors>Kim H</pubmed_authors><pubmed_authors>Bae SH</pubmed_authors><pubmed_authors>Lee SC</pubmed_authors><pubmed_authors>Lee H</pubmed_authors><pubmed_authors>Kim JW</pubmed_authors><pubmed_authors>Lee EW</pubmed_authors><pubmed_authors>Lee JY</pubmed_authors><pubmed_authors>Oh KJ</pubmed_authors><pubmed_authors>Kim S</pubmed_authors><pubmed_authors>Kim WK</pubmed_authors><pubmed_authors>Bae KH</pubmed_authors><pubmed_authors>Ban HS</pubmed_authors><pubmed_authors>Han TH</pubmed_authors><pubmed_authors>Han BS</pubmed_authors><pubmed_authors>Kim MJ</pubmed_authors></additional><is_claimable>false</is_claimable><name>FSP1 confers ferroptosis resistance in KEAP1 mutant non-small cell lung carcinoma in NRF2-dependent and -independent manner.</name><description>Ferroptosis, a type of cell death induced by lipid peroxidation, has emerged as a novel anti-cancer strategy. Cancer cells frequently acquire resistance to ferroptosis. However, the underlying mechanisms are poorly understood. To address this issue, we conducted a thorough investigation of the genomic and transcriptomic data derived from hundreds of human cancer cell lines and primary tissue samples, with a particular focus on non-small cell lung carcinoma (NSCLC). It was observed that mutations in Kelch-like ECH-associated protein 1 (KEAP1) and subsequent nuclear factor erythroid 2-related factor 2 (NRF2, also known as NFE2L2) activation are strongly associated with ferroptosis resistance in NSCLC. Additionally, AIFM2 gene, which encodes ferroptosis suppressor protein 1 (FSP1), was identi</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Aug</publication><modification>2025-04-04T10:10:04.043Z</modification><creation>2025-04-04T10:10:04.043Z</creation></dates><accession>S-EPMC10460413</accession><cross_references><pubmed>37633973</pubmed><doi>10.1038/s41419-023-06070-x</doi></cross_references></HashMap>